Found: 2

Select item for more details and to access through your institution.

  • RHOA<sup>L57V</sup> drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.

    Published in:
    Science Signaling, 2023, v. 16, n. 816, p. 1, doi. 10.1126/scisignal.adg5289
    By:
    • Schaefer, Antje;
    • Hodge, Richard G.;
    • Zhang, Haisheng;
    • Hobbs, G. Aaron;
    • Dilly, Julien;
    • Huynh, Minh V.;
    • Goodwin, Craig M.;
    • Zhang, Feifei;
    • Diehl, J. Nathaniel;
    • Pierobon, Mariaelena;
    • Baldelli, Elisa;
    • Javaid, Sehrish;
    • Guthrie, Karson;
    • Rashid, Naim U.;
    • Petricoin, Emanuel F.;
    • Cox, Adrienne D.;
    • Hahn, William C.;
    • Aguirre, Andrew J.;
    • Bass, Adam J.;
    • Der, Channing J.
    Publication type:
    Article

  • Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

    Published in:
    Science Signaling, 2019, v. 12, n. 590, p. 1, doi. 10.1126/scisignal.aav7259
    By:
    • Blake, Devon R.;
    • Vaseva, Angelina V.;
    • Hodge, Richard G.;
    • Kline, McKenzie P.;
    • Gilbert, Thomas S. K.;
    • Tyagi, Vikas;
    • Huang, Daowei;
    • Whiten, Gabrielle C.;
    • Larson, Jacob E.;
    • Wang, Xiaodong;
    • Pearce, Kenneth H.;
    • Herring, Laura E.;
    • Graves, Lee M.;
    • Frye, Stephen V.;
    • Emanuele, Michael J.;
    • Cox, Adrienne D.;
    • Der, Channing J.
    Publication type:
    Article